Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Brugia malayi | TAR-binding protein | 0.0064 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.1923 | 0.4849 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.2592 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0025 | 0.2592 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0018 | 0.1293 | 0.1293 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0025 | 0.2592 | 0.1493 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 1 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0025 | 0.2592 | 0.1493 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.1923 | 0.1923 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0018 | 0.1293 | 0.4987 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0018 | 0.1293 | 0.1293 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 1 | 1 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0018 | 0.13 | 1 |
Echinococcus granulosus | serine protein kinase ATM | 0.0025 | 0.2592 | 0.1493 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0018 | 0.13 | 0.0052 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0025 | 0.2592 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Giardia lamblia | GTOR | 0.0018 | 0.1293 | 0.5 |
Toxoplasma gondii | FATC domain-containing protein | 0.0025 | 0.2592 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0018 | 0.1293 | 0.4987 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0025 | 0.2592 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0025 | 0.2592 | 0.1493 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.1293 | 0.4987 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.